Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

about

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

Item

http://www.wikidata.org/entity/Q58621562

description

scientific article published on 24 May 2017

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2017

@uk

name

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

@en

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

@nl

type

Item

label

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

@en

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

@nl

prefLabel

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

@en

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

@nl

P1476

Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

@en

P2093

A Fel

http://www.w3.org/2001/XMLSchema#string

A L Remond

http://www.w3.org/2001/XMLSchema#string

C Bottin

http://www.w3.org/2001/XMLSchema#string

F Domont

http://www.w3.org/2001/XMLSchema#string

J F Alexandra

http://www.w3.org/2001/XMLSchema#string

L Savey

http://www.w3.org/2001/XMLSchema#string

N Butel

http://www.w3.org/2001/XMLSchema#string

V Touitou

http://www.w3.org/2001/XMLSchema#string

P2860

Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview

Scleritis and episcleritis.

Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease.

Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature.

Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents.

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.

Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.

Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies.

Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.

Biologic therapy for refractory scleritis: a new treatment perspective.

P304

915-920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09273948.2017.1299869

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28537473

http://www.w3.org/2001/XMLSchema#string